Literature DB >> 30012374

Short- and long-term gene expression profiles induced by inhaled TiO2 nanostructured aerosol in rat lung.

Laëtitia Chézeau1, Sylvie Sébillaud2, Ramia Safar3, Carole Seidel2, Doulaye Dembélé4, Mylène Lorcin2, Cristina Langlais2, Stéphane Grossmann2, Hervé Nunge2, Sylvie Michaux2, Hélène Dubois-Pot-Schneider5, Bertrand Rihn6, Olivier Joubert6, Stéphane Binet2, Frédéric Cosnier2, Laurent Gaté7.   

Abstract

The number of workers potentially exposed to nanoparticles (NPs) during industrial processes is increasing, although the toxicological properties of these compounds still need to be fully characterized. As NPs may be aerosolized during industrial processes, inhalation represents their main route of occupational exposure. Here, the short- and long-term pulmonary toxicological properties of titanium dioxide were studied, using conventional and molecular toxicological approaches. Fischer 344 rats were exposed to 10 mg/m3 of a TiO2 nanostructured aerosol (NSA) by nose-only inhalation for 6 h/day, 5 days/week for 4 weeks. Lung samples were collected up to 180 post-exposure days. Biochemical and cytological analyses of bronchoalveolar lavage (BAL) showed a strong inflammatory response up to 3 post-exposure days, which decreased overtime. In addition, gene expression profiling revealed overexpression of genes involved in inflammation that was maintained 6 months after the end of exposure (long-term response). Genes involved in oxidative stress and vascular changes were also up-regulated. Long-term response was characterized by persistent altered expression of a number of genes up to 180 post-exposure days, despite the absence of significant histopathological changes. The physiopathological consequences of these changes are not fully understood, but they should raise concerns about the long-term pulmonary effects of inhaled biopersistent NPs such as TiO2.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gene expression profile; Lung inflammation; Short- and long-term response; Titanium dioxide

Mesh:

Substances:

Year:  2018        PMID: 30012374     DOI: 10.1016/j.taap.2018.07.013

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Retained particle surface area dose drives inflammation in rat lungs following acute, subacute, and subchronic inhalation of nanomaterials.

Authors:  Frédéric Cosnier; Carole Seidel; Sarah Valentino; Otmar Schmid; Sébastien Bau; Ulla Vogel; Jérôme Devoy; Laurent Gaté
Journal:  Part Fibre Toxicol       Date:  2021-08-05       Impact factor: 9.400

2.  Adverse Outcome Pathway Development for Assessment of Lung Carcinogenicity by Nanoparticles.

Authors:  Penny Nymark; Hanna L Karlsson; Sabina Halappanavar; Ulla Vogel
Journal:  Front Toxicol       Date:  2021-04-29

3.  In Vitro Molecular Study of Titanium-Niobium Alloy Biocompatibility.

Authors:  Laëtitia Chézeau; Alex Tchinda; Gaël Pierson; Pierre Bravetti; Luc Ferrari; Olivier Joubert; Mohamed Zaiou; Bertrand H Rihn
Journal:  Biomedicines       Date:  2022-08-05

4.  Biocompatibility of ZrO2 vs. Y-TZP Alloys: Influence of Their Composition and Surface Topography.

Authors:  Alex Tchinda; Laëtitia Chézeau; Gaël Pierson; Richard Kouitat-Njiwa; B H Rihn; Pierre Bravetti
Journal:  Materials (Basel)       Date:  2022-07-01       Impact factor: 3.748

5.  Exposure to TiO2 Nanostructured Aerosol Induces Specific Gene Expression Profile Modifications in the Lungs of Young and Elderly Rats.

Authors:  Sarah A Valentino; Laëtitia Chézeau; Carole Seidel; Sylvie Sébillaud; Mylène Lorcin; Monique Chalansonnet; Frédéric Cosnier; Laurent Gaté
Journal:  Nanomaterials (Basel)       Date:  2021-06-01       Impact factor: 5.076

6.  Toxicity of TiO2 Nanoparticles: Validation of Alternative Models.

Authors:  Mélanie M Leroux; Zahra Doumandji; Laetitia Chézeau; Laurent Gaté; Sara Nahle; Romain Hocquel; Vadim Zhernovkov; Sylvie Migot; Jafar Ghanbaja; Céline Bonnet; Raphaël Schneider; Bertrand H Rihn; Luc Ferrari; Olivier Joubert
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.